These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7887652)

  • 1. [Cross resistance of a new platinum analogue, ACT-078, to CDDP and CBDCA].
    Misawa T; Higashide K; Konda C; Maeda O; Hasegawa N; Kikkawa F; Tomoda Y
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):569-71. PubMed ID: 7887652
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
    Chang MJ; Yu WD; Reyno LM; Modzelewski RA; Egorin MJ; Erkmen K; Vlock DR; Furmanski P; Johnson CS
    Cancer Res; 1994 Oct; 54(20):5380-6. PubMed ID: 7923169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.
    Jones M; Siracky J; Kelland LR; Harrap KR
    Br J Cancer; 1993 Jan; 67(1):24-9. PubMed ID: 8427780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study on the anti-tumor effect of CDDP derivatives against the gastric cancer cell lines].
    Nitta A; Chung YS; Kato Y; Yashiro M; Maeda K; Kubo T; Nakata B; Okuno M; Sowa M
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):701-3. PubMed ID: 8154897
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line.
    Negoro K; Yamano Y; Nakashima D; Saito K; Nakatani K; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Wada T; Tanzawa H; Fujita S
    Oncol Rep; 2009 Feb; 21(2):443-9. PubMed ID: 19148521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic activity of [Pt(pyr)(N-Etlm)Cl4].
    Massacesi M; Matovic Z; Ponticelli G
    Farmaco; 1993 Sep; 48(9):1327-30. PubMed ID: 8259989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
    Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study on combination chemotherapy with platinum compounds and 5-fluorouracil].
    Furukawa S; Yoshida T; Tukuda M; Yanoma S; Ryo I; Miyata K; Kubota A; Mochimatsu I; Sawaki S
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):419-22. PubMed ID: 2649008
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
    J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin.
    Reed E
    Cancer Chemother Biol Response Modif; 1990; 11():90-6. PubMed ID: 2223411
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
    Holzer AK; Manorek GH; Howell SB
    Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicine-platinum anticancer agents correlates with their chemical reactivity towards sulfur-containing nucleophiles.
    To KK; Au-Yeung SC; Ho YP
    Anticancer Drugs; 2006 Jul; 17(6):673-83. PubMed ID: 16917213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction between platinum-based antitumor agents and demethylcantharidin.
    To KK; Ho YP; Au-Yeung SC
    Cancer Lett; 2005 Jun; 223(2):227-37. PubMed ID: 15896457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    Kelland LR; Sharp SY; O'Neill CF; Raynaud FI; Beale PJ; Judson IR
    J Inorg Biochem; 1999 Oct; 77(1-2):111-5. PubMed ID: 10626362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cytotoxicities of platinum compounds.
    Goodisman J; Hagrman D; Tacka KA; Souid AK
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ultrafilterable platinum concentration on cisplatin and carboplatin cytotoxicity in human tumor and bone marrow cells in vitro.
    Guchelaar HJ; de Vries EG; Meijer C; Esselink MT; Vellenga E; Uges DR; Mulder NH
    Pharm Res; 1994 Sep; 11(9):1265-9. PubMed ID: 7816754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.
    Monk BJ; Alberts DS; Burger RA; Fanta PT; Hallum AV; Hatch KD; Salmon SE
    Gynecol Oncol; 1998 Nov; 71(2):308-12. PubMed ID: 9826477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G; Kusumoto T; Korbut TT; Cullere-Luengo F; Teicher BA
    Cancer Res; 1994 Mar; 54(6):1497-502. PubMed ID: 8137254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA.
    Los G; van Vugt MJ; den Engelse L; Pinedo HM
    Biochem Pharmacol; 1993 Oct; 46(7):1229-37. PubMed ID: 8216374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.